v3.25.2
Earnings per Share (Details) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Numerator:        
Net income attributable to Biogen Inc. $ 634.8 $ 583.6 $ 875.3 $ 977.0
Weighted-average shares used in calculating:        
Weighted average number of common shares outstanding 146,500 145,600 146,300 145,400
Effect of dilutive securities:        
Dilutive potential common shares 200 300 400 500
Shares used in calculating diluted earnings per share 146,700 145,900 146,700 145,900
Time-vested restricted stock units        
Effect of dilutive securities:        
Stock units 200 200 300 400
Performance stock units settled in stock        
Effect of dilutive securities:        
Stock units 0 100 100 100